142 related articles for article (PubMed ID: 37852211)
1. A Systematic Review and Bayesian Network Meta-Analysis of Medical Therapies for Lichen Planopilaris.
Husein-ElAhmed H; Husein-ElAhmed S
Dermatology; 2024; 240(1):103-110. PubMed ID: 37852211
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of oral pioglitazone in the management of lichen planopilaris in comparison with clobetasol: A randomized clinical trial.
Lajevardi V; Ghiasi M; Balighi K; Daneshpazhooh M; Azar PM; Kianfar N; Dasdar S; Peymanfar AA
Dermatol Ther; 2022 Nov; 35(11):e15868. PubMed ID: 36169160
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, safety, tolerability, and satisfaction of N-acetylcysteine and pentoxifylline in lichen planopilaris patients under treatment with topical clobetasol: A triple arm blinded randomized controlled trial.
Ahmadi Kahjoogh H; Yazdanian N; Behrangi E; Roohaninasab M; Hejazi P; Goodarzi A
Dermatol Ther; 2022 Aug; 35(8):e15639. PubMed ID: 35703373
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporine or methotrexate, which one is more promising in the treatment of lichen planopilaris?; A comparative clinical trial.
Fatemi Naeini F; Mohaghegh F; Jelvan M; Asilian A; Saber M
Int Immunopharmacol; 2020 Sep; 86():106765. PubMed ID: 32674048
[TBL] [Abstract][Full Text] [Related]
5. Comparison of systemic mycophenolate mofetil with topical clobetasol in lichen planopilaris: a parallel-group, assessor- and analyst-blinded, randomized controlled trial.
Lajevardi V; Ghodsi SZ; Goodarzi A; Hejazi P; Azizpour A; Beygi S
Am J Clin Dermatol; 2015 Aug; 16(4):303-311. PubMed ID: 25786714
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of oral low dose naltrexone versus placebo in the patients with lichen planopilaris: a randomized controlled clinical trial.
Lajevardi V; Salarvand F; Ghiasi M; Nasimi M; Taraz M
J Dermatolog Treat; 2022 Mar; 33(2):769-773. PubMed ID: 32449418
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil and lichen planopilaris: systematic review and meta-analysis.
Mostafa N; Phan K; Smith S
J Dermatolog Treat; 2022 Feb; 33(1):369-372. PubMed ID: 32281437
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of mycophenolate mofetil for lichen planopilaris.
Cho BK; Sah D; Chwalek J; Roseborough I; Ochoa B; Chiang C; Price VH
J Am Acad Dermatol; 2010 Mar; 62(3):393-7. PubMed ID: 20061053
[TBL] [Abstract][Full Text] [Related]
9. Lichen planopilaris in a Latin American (Chilean) population: demographics, clinical profile and treatment experience.
Mardones F; Shapiro J
Clin Exp Dermatol; 2017 Oct; 42(7):755-759. PubMed ID: 28748570
[TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine and lichen planopilaris: efficacy and introduction of Lichen Planopilaris Activity Index scoring system.
Chiang C; Sah D; Cho BK; Ochoa BE; Price VH
J Am Acad Dermatol; 2010 Mar; 62(3):387-92. PubMed ID: 20061052
[TBL] [Abstract][Full Text] [Related]
11. Lichen planopilaris in men: a retrospective clinicopathologic study of 19 patients.
Cantwell HM; Wieland CN; Proffer SL; Imhof RL; Torgerson RR; Tolkachjov SN
Int J Dermatol; 2021 Apr; 60(4):482-488. PubMed ID: 33128471
[TBL] [Abstract][Full Text] [Related]
12. Treatment Patterns for Hydroxychloroquine, Methotrexate, and Mycophenolate Mofetil in Lichen Planopilaris: A Retrospective Chart Review.
Williams J; Lacy A; Ranpariya VK; Pichardo RO
J Cutan Med Surg; 2023; 27(4):403-405. PubMed ID: 37559372
[No Abstract] [Full Text] [Related]
13. Platelet-rich plasma as a new and successful treatment for lichen planopilaris: A controlled blinded randomized clinical trial.
Behrangi E; Akbarzadehpasha A; Dehghani A; Zare S; Ghassemi M; Zeinali R; Goodarzi A; Lotfi Z
J Cosmet Dermatol; 2024 Mar; ():. PubMed ID: 38525908
[TBL] [Abstract][Full Text] [Related]
14. JAK Inhibitors in the Treatment of Lichen Planopilaris.
Nasimi M; Ansari MS
Skin Appendage Disord; 2024 Feb; 10(1):10-17. PubMed ID: 38313572
[TBL] [Abstract][Full Text] [Related]
15. Treatment of lichen planopilaris: methotrexate or cyclosporine a therapy?
Bulbul Baskan E; Yazici S
Cutan Ocul Toxicol; 2018 Jun; 37(2):196-199. PubMed ID: 28944688
[TBL] [Abstract][Full Text] [Related]
16. Interventions for treating oral lichen planus: corticosteroid therapies.
Lodi G; Manfredi M; Mercadante V; Murphy R; Carrozzo M
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD001168. PubMed ID: 32108333
[TBL] [Abstract][Full Text] [Related]
17. Frontal fibrosing alopecia among men: A clinicopathologic study of 7 cases.
Tolkachjov SN; Chaudhry HM; Camilleri MJ; Torgerson RR
J Am Acad Dermatol; 2017 Oct; 77(4):683-690.e2. PubMed ID: 28716436
[TBL] [Abstract][Full Text] [Related]
18. Co-localization of alopecia areata and lichen planopilaris in a patient receiving immunosuppressants: A rare case.
Mofarrah R; Mofarrah R; Jahani Amiri K; Ghasemi M
J Cosmet Dermatol; 2021 Mar; 20(3):976-979. PubMed ID: 33167077
[TBL] [Abstract][Full Text] [Related]
19. Lichen planopilaris: retrospective study on the characteristics and treatment of 291 patients.
Babahosseini H; Tavakolpour S; Mahmoudi H; Balighi K; Teimourpour A; Ghodsi SZ; Abedini R; Ghandi N; Lajevardi V; Kiani A; Kamyab K; Mohammadi M; Daneshpazhooh M
J Dermatolog Treat; 2019 Sep; 30(6):598-604. PubMed ID: 30411987
[TBL] [Abstract][Full Text] [Related]
20. Pediatric ocular lichen planus and lichen planopilaris: One new case and a review of the literature.
Bevans SL; Theos AJ; Fowler PG; Pavlidakey PG; Stoll M; Sami N
Pediatr Dermatol; 2018 Nov; 35(6):859-863. PubMed ID: 30168195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
